Periventricular Lesions Drive Cognitive Decline by Disrupting Cholinergic Pathways in Parkinson's

Cholinergic Integrity and Cognitive Vulnerability in Parkinson’s Disease

Cognitive impairment remains a debilitating non-motor complication of Parkinson’s disease, often emerging before the onset of frank dementia. While dopaminergic deficits define the motor phenotype, the progression of cognitive symptoms is increasingly linked to the loss of cholinergic neurons and the accumulation of vascular white matter injury [1, 2]. Chronic neuroinflammation and oxidative stress, a state where reactive oxygen species overwhelm antioxidant defenses, exacerbate these processes to create a precarious environment for long-range projection fibers [3, 4]. To understand this mechanism, a recent study of 127 patients with mid to advanced-stage Parkinson’s disease utilized [5]-FEOBV positron emission tomography, a specialized imaging technique that labels presynaptic cholinergic terminals, to demonstrate how structural lesions disrupt specific cognitive networks [2]. The researchers found that higher periventricular white matter lesion burden was significantly associated with reduced cholinergic uptake in an insular-limbic-frontal-cingulum cluster, affecting the lateral and external Ch4 cholinergic projection pathways in 81% to 88% of patients [2]. For practicing clinicians, these findings suggest that periventricular lesions drive cognitive decline through both direct cortical terminal disruption and indirect retrograde degeneration, the death of a cell body resulting from axonal injury, of the basal forebrain [2].

Mapping Structural Disruption in the Parkinsonian Brain

To investigate the neurobiological mechanisms linking white matter injury to cognitive decline, researchers analyzed a cohort of 127 patients with mid to advanced-stage Parkinson’s disease who had not yet developed dementia. The study utilized a multimodal imaging approach to test a mechanistic model of how white matter lesions affect the basal forebrain cholinergic projections and nuclei. The team employed T1-weighted magnetic resonance imaging as a volumetric proxy for the basal forebrain nuclei, which serve as the primary source of cholinergic projections in the brain. To quantify the burden of white matter injury, they used fluid-attenuated inversion recovery magnetic resonance imaging, a sequence that suppresses fluid signals to make lesions more visible. These scans were processed through the UBO Detector pipeline, an automated software tool that differentiates between periventricular lesions located near the brain ventricles and deep white matter lesions.

The assessment of cholinergic integrity was further refined using positron emission tomography with [18F]-FEOBV, a radiotracer that serves as a specific presynaptic cholinergic marker to measure synaptic density. This allowed the team to map exactly how structural damage correlates with the loss of functional cholinergic terminals. Alongside these imaging modalities, the researchers conducted a comprehensive neuropsychological evaluation. Cognitive function was assessed across five distinct domains using z-scores derived from a control group matched for age and education, ensuring that any observed deficits were specific to the disease process rather than normal aging. By integrating these quantitative lesion assessments with high-resolution imaging and standardized cognitive data, the study established that white matter lesions are directly associated with cognitive impairment in Parkinson’s disease through the disruption of long-range cholinergic pathways.

Topography of White Matter Injury and Synaptic Loss

The researchers conducted voxel-wise analyses, a statistical method that examines every individual three-dimensional pixel in a brain scan to identify localized differences, to investigate the associations between white matter lesion burden and cholinergic synaptic density. These analyses revealed that a higher burden of periventricular lesions was associated with reduced [18F]-FEOBV uptake within a specific insular-limbic-frontal-cingulum cluster, indicating a significant loss of cholinergic terminals in these critical cognitive regions. While deep white matter lesions also showed associations with synaptic density, these were more topographically limited. Furthermore, the associations between deep lesions and cholinergic loss disappeared entirely after the researchers adjusted for periventricular lesion burden, suggesting that periventricular injury is the primary driver of these neurobiological changes.

The study further delineated the impact of lesion location on specific neuroanatomical pathways, particularly the Ch4 cholinergic projection pathways originating from the nucleus basalis of Meynert, a major neuromodulatory hub. Periventricular lesions affected the lateral and external Ch4 cholinergic projection pathways in 81% to 88% of patients, representing a substantial majority of the cohort. In contrast, deep white matter lesions affected these same lateral and external Ch4 pathways in only 25% to 47% of patients. One notable exception was the external capsule, a thin layer of white matter situated between the putamen and the claustrum, which the researchers found was equally affected by both periventricular and deep white matter lesions. These findings suggest that periventricular damage has a more pervasive and systematic impact on the cholinergic architecture necessary for cognitive health in Parkinson's disease than deep white matter injury.

Mechanisms of Cognitive Impairment and Retrograde Atrophy

The researchers established that cognitive performance across global cognition, memory, executive function, and attention was significantly associated with periventricular lesion burden. Furthermore, cognitive scores correlated with [18F]-FEOBV uptake within the insular, limbic, frontal, and cingulum cluster, as well as with basal forebrain volume. To clarify these relationships, the authors performed mediation analyses, statistical methods used to determine if the effect of an independent variable on a dependent variable is explained by an intervening third variable. These models were adjusted for sex, levodopa equivalent dose, and disease duration to ensure the findings were not confounded by clinical or demographic factors.

The analysis identified two distinct pathways through which periventricular lesions impair cognition. First, these lesions exerted a direct effect on cortical terminal integrity, as measured by [18F]-FEOBV positron emission tomography. Second, the researchers observed an indirect effect through basal forebrain atrophy, which they characterized as a result of retrograde degeneration, a process where damage to an axon causes the death of the parent cell body. Specifically, the reduction in cholinergic terminal density within the insular, limbic, frontal, and cingulum cluster served as a strong mediator of the association between periventricular lesion burden and cognitive performance.

The strength of these mediation effects varied depending on the cognitive domain being assessed. While a weaker mediation effect via the basal forebrain emerged for global cognition, the mediation was more robust for memory and executive functioning. For practicing physicians, these results indicate that periventricular white matter lesions contribute to cognitive vulnerability in Parkinson’s disease without dementia by disrupting basal forebrain cholinergic projections. Consequently, quantifying white matter lesion burden on routine imaging may serve as a mechanistically meaningful biomarker for predicting cognitive trajectories, potentially helping clinicians identify at-risk patients and inform targeted interventions earlier in the disease course.

References

1. Salari N, Rasoulpoor S, Hosseinian-Far A, et al. Association between serum paraoxonase 1 activity and its polymorphisms with multiple sclerosis: a systematic review.. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2021. doi:10.1007/s10072-020-04842-3

2. Carli G, Brown T, Michalakis F, et al. White matter lesions disrupt cholinergic pathways important for cognition in Parkinson's disease.. Brain : a journal of neurology. 2026. doi:10.1093/brain/awag172

3. Zhang W, Xiao D, Mao Q, Xia H. Role of neuroinflammation in neurodegeneration development. Signal Transduction and Targeted Therapy. 2023. doi:10.1038/s41392-023-01486-5

4. Birben E, Şahiner ÜM, Saçkesen C, Erzurum SC, Kalaycı Ö. Oxidative Stress and Antioxidant Defense. World Allergy Organization Journal. 2012. doi:10.1097/wox.0b013e3182439613

5. Anwar MM, Heartshorne R, Alusi SH. Extrapyramidal Movement Disorders in Multiple Sclerosis Patients: A Systematic Review. 2025. doi:10.3390/sclerosis3040042